ABSTRACT

Stroke remains one of the major causes of death and long-term disability worldwide. Currently, the only approved therapy for the acute treatment of this disease is thrombolysis, a strategy that can only be applied to a small percentage of patients due to its narrow therapeutic window. Unfortunately, during the last years numerous promising drugs th

chapter 5|22 pages

Risk Factors and Restroke Prevention

chapter 7|12 pages

Acute Stroke Imaging and Beyond

chapter 19|14 pages

Therapeutic Hypothermia for Acute Stroke

chapter 25|22 pages

Cell-Based Therapies for Stroke